Literature DB >> 18491030

Fever of unknown origin secondary to type I crescentic glomerulonephritis and anti-SCl 70 antibodies without clinical manifestations of systemic sclerosis.

Jorge Vega Stieb1,2,3, Helmuth Goecke Saavedra4,5, Gonzalo Méndez Olivieri6.   

Abstract

A 57-year-old woman presented with fever and cellulitis of the right leg. Urinalysis and kidney function were normal on admission. Cellulitis remitted but fever persisted for six weeks. X-ray imaging, cultures, serological assays for viruses and autoimmunity did not reveal the cause of fever. Unexpectedly anti-Scl 70 (anti-topoisomerase I) antibodies were positive. A skin biopsy ruled out scleroderma. On the fifth hospitalization week kidney function declined in association with hematuria, leucocyturia, and proteinuria. Prednisone was administered due to clinical suspicion of drug-induced interstitial nephritis. Fever declined in 24 h, but renal failure became rapidly worse requiring hemodialysis. Kidney biopsy revealed extensive crescentic glomerulonephritis (CGN), with much glomerular destruction, with an IgG-positive linear pattern on immunofluorescence microscopy. No overtly active microangiopathy or vasculitis were present. There was no pulmonary involvement and anti-glomerular basement membrane antibodies were not detected in the serum. After one year anti-Scl 70 antibodies were still positive without scleroderma manifestations and 17 months later the patient received a kidney transplant with excellent results. Presentation of type 1 CGN as a fever of unknown origin (FUO) is exceptional. Anti-Scl 70 antibodies are highly specific for scleroderma and are seldom present in other diseases. As far as we are aware there are no published cases of the association of type 1 CGN with anti-Scl 70 antibodies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18491030     DOI: 10.1007/s10157-008-0057-2

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  41 in total

1.  Systemic sclerosis and antineutrophil cytoplasmic autoantibody-associated renal failure.

Authors:  A Katrib; A Sturgess; J V Bertouch
Journal:  Rheumatol Int       Date:  1999       Impact factor: 2.631

2.  The alpha 5 chain of type IV collagen is the target of IgG autoantibodies in a novel autoimmune disease with subepidermal blisters and renal insufficiency.

Authors:  R F Ghohestani; B G Hudson; A Claudy; J Uitto
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

Review 3.  Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodies.

Authors:  G Spencer-Green; D Alter; H G Welch
Journal:  Am J Med       Date:  1997-09       Impact factor: 4.965

4.  Autoantibodies against topoisomerase I detected with the natural enzyme and overlapping recombinant peptides.

Authors:  H P Seelig; H Schröter; H Ehrfeld; M Renz
Journal:  J Immunol Methods       Date:  1993-10-15       Impact factor: 2.303

5.  Expression of DNA topoisomerases in chronic proliferative kidney disease.

Authors:  L V Ivanova; P Rudolph; U Kellner; A Jürgensen; I E Tareeva; P Alm; D Proppe
Journal:  Kidney Int       Date:  2000-10       Impact factor: 10.612

6.  [A case of systemic sclerosis with crescentic glomerulonephritis associated with perinuclear-antineutrophil cytoplasmic antibody (p-ANCA)].

Authors:  S Harashima; S Yoshizawa; T Horiuchi; H Nakashima; Y Niho; T Kusaba; I Hayashida; M Shinozaki; R Katafuchi; H Hirakata
Journal:  Nihon Rinsho Meneki Gakkai Kaishi       Date:  1999-04

7.  Fibrillary glomerulonephritis: an entity with unusual immunofluorescence features.

Authors:  C E Alpers; H G Rennke; J Hopper; C G Biava
Journal:  Kidney Int       Date:  1987-03       Impact factor: 10.612

Review 8.  Scleroderma associated with ANCA-associated vasculitis.

Authors:  Young Hee Rho; Seong Jae Choi; Young Ho Lee; Jong Dae Ji; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2005-07-20       Impact factor: 2.631

9.  Antitopoisomerase I antibody in patients with systemic lupus erythematosus/sicca syndrome without a concomitant scleroderma: two case reports.

Authors:  H M Al Attia; M S D'Souza
Journal:  Clin Rheumatol       Date:  2003-02       Impact factor: 2.980

10.  Anti-glomerular basement membrane nephritis and bullous pemphigoid caused by distinct anti-alpha 3(IV)NC1 and anti-BP180 antibodies in a patient with Crohn's disease.

Authors:  Emmanuelle Plaisier; Luca Borradori; Thomas Hellmark; Marie-José Wattiaux; Béatrice Flageul; Béatrice Mougenot; Pierre Ronco
Journal:  Am J Kidney Dis       Date:  2002-09       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.